Sponsor pipeline

AbbVie clinical trial pipeline

Get alerts when AbbVie's trials change

243 active trials 116 recruiting 73 Phase 3 45 disease areas 85 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days showing 49 of 85 changes on 20 trials

2026-08-29
Withdrawn before enrolling
Trial withdrawn: Company Decision
NCT07604545 A Study to Assess the Use of Artificial Intellignce to Predict Eye Treatment Changes in…
2026-09-05
Primary completion pushed: 2023-09-06 → 2024-10-02
Primary endpoint(s) modified
Results posted: 2026-09-04
NCT03386513 Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN · Phase 1/2
2026-09-03
Primary completion pushed: 2026-03 → 2027-03
Completion pushed: 2026-03 → 2027-03
NCT03893955 A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy… · Phase 1
2026-08-15
Primary completion pushed: 2027-06 → 2027-11
Completion pushed: 2027-09 → 2027-11
NCT06417775 Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult… · Phase 3
2026-08-08
Primary completion pushed: 2026-05 → 2029-02
Completion pushed: 2026-05 → 2029-02
NCT03105102 A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease · Phase 3
2026-08-07
Primary completion pushed: 2029-11 → 2030-07
Completion pushed: 2029-11 → 2030-07
NCT06461897 A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… · Phase 3
2026-08-22
Primary completion pushed: 2026-06 → 2027-02
Enrollment closed, study ongoing
Completion moved earlier: 2027-06 → 2027-02
NCT06365853 A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab… · Phase 2
2026-08-20
Primary completion pushed: 2029-05 → 2030-12
Enrollment reduced: 110 → 66 participants
Enrollment closed, study ongoing
Completion pushed: 2029-05 → 2030-12
NCT02966756 A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic… · Phase 2
2026-08-08
Primary completion pushed: 2026-10 → 2027-03
Enrollment increased: 48 → 80 participants
Completion pushed: 2026-10 → 2027-03
Trial arms changed: 4 → 8
NCT07291232 A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics… · Phase 1
2026-08-07
Primary completion pushed: 2025-11 → 2027-02
Trial status changed: Active, Not Recruiting → Not Yet Recruiting
Completion pushed: 2025-11 → 2027-02
NCT07071532 A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given… · Phase 1
2026-09-03
Enrollment reduced: 16 → 14 participants
NCT07387471 Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With… · Phase 2
2026-08-18
Enrollment reduced: 20 → 3 participants
Enrollment closed, study ongoing
Primary completion moved earlier: 2027-10 → 2027-02
Completion moved earlier: 2027-10 → 2027-02
NCT06487559 A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in… · Phase 1
2026-08-15
Enrollment reduced: 165 → 21 participants
Enrollment closed, study ongoing
Primary completion pushed: 2027-01 → 2027-04
Completion moved earlier: 2031-11 → 2027-04
NCT06667687 Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously… · Phase 1
2026-09-01
Recruitment opened
Trial sites expanded: 0 → 33 locations
NCT07752979 Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related… · Phase 2
2026-09-01
Enrollment closed, study ongoing
NCT07604558 A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves… · Phase 1
2026-09-01
Trial completed
NCT07414784 A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events… · Phase 1
2026-08-28
Enrollment closed, study ongoing
Enrollment increased: 380 → 421 participants
NCT06158841 Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard… · Phase 3
2026-09-02
Recruitment opened
Trial sites expanded: 1 → 10 locations
NCT07227896 Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult…
2026-08-29
Recruitment opened
Trial sites reduced: 30 → 21 locations
NCT07697456 Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to… · Phase 2
2026-08-29
Enrollment closed, study ongoing
Primary completion pushed: 2026-07 → 2026-09
Completion pushed: 2026-07 → 2026-09
NCT07599761 A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult… · Phase 1

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-08-31 NCT07794878 Study to Assess Adverse Events and How Effective NOA LIFT is Compared to JUVÉDERM VOLIFT… Phase 3 Recruiting
2026-08-31 NCT07794891 Study to Assess Participant Satisfaction After Jawline and Neck Treatment Phase 4 Not Yet Recruiting
2026-08-28 NCT07793422 Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig… Phase 3 Not Yet Recruiting
2026-08-19 NCT07772492 A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric… Phase 3 Recruiting
2026-08-18 NCT07769502 A Study to Assess Adverse Events and Change in Disease Activity With Treatment… Phase 2 Not Yet Recruiting
2026-08-10 NCT07756580 A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by… Phase 1 Not Yet Recruiting
2026-08-10 NCT07756645 A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab… Phase 3 Not Yet Recruiting
2026-08-07 NCT07752979 Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related… Phase 2 Recruiting

Active trials by phase

Phase 1
53
Phase 1/2
10
Phase 2
48
Phase 2/3
10
Phase 3
63
Phase 4
4
Not charted: 55 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 243

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07044687 Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in… Acute Myeloid Leukemia Recruiting 2026-08-14
NCT07794891 Study to Assess Participant Satisfaction After Jawline and Neck Treatment Jawline and Neck Appearance Not Yet Recruiting 2026-08-31
NCT05821855 A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma… Open-angle Glaucoma Active, Not Recruiting 2026-04-28
NCT05144243 Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in… Acute Myeloid Leukemia (AML) Active, Not Recruiting 2025-08-12
Phase 3
NCT07007065 Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and… Neovascular Age-related Macular Degeneration Recruiting 2026-09-04
NCT07071519 A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative… Ulcerative Colitis Recruiting 2026-09-04
NCT05711394 A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant… Episodic Migraine Recruiting 2026-09-03
NCT06810505 A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity… Chronic Migraine Recruiting 2026-09-03
NCT07365241 A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706… Small Cell Lung Cancer Recruiting 2026-09-02
NCT05125302 Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the… Migraine Recruiting 2026-09-01
NCT06100744 A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves… Juvenile Psoriatic Arthritis Recruiting 2026-09-01
NCT07794878 Study to Assess Adverse Events and How Effective NOA LIFT is Compared to JUVÉDERM VOLIFT… Nasolabial Folds Recruiting 2026-08-31
NCT07772492 A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric… Severe Alopecia Areata Recruiting 2026-08-25
NCT05609630 Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in… Juvenile Idiopathic Arthritis Recruiting 2026-08-14
NCT06822738 A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation… Primary Open Angle Glaucoma Recruiting 2026-08-14
NCT06461897 A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… Atopic Dermatitis Recruiting 2026-08-06
NCT06575192 Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast… Breast Reconstruction Recruiting 2026-08-06
NCT06012240 A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… Alopecia Areata Recruiting 2026-08-03
NCT07525206 A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV… Colorectal Cancer Recruiting 2026-07-29
NCT04928846 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab… Non Small Cell Lung Cancer Recruiting 2026-07-28
NCT04777357 A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in… Depression Recruiting 2026-07-27
NCT06389136 A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis… Atopic Dermatitis Recruiting 2026-07-06
NCT06332534 Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric… Crohn's Disease Recruiting 2026-06-24
NCT06734351 A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult… Mid Face Volume Deficit Recruiting 2026-06-18
NCT05995353 A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and… Crohn's Disease Recruiting 2026-05-29
See all 243 active AbbVie trials with filters →

Disease areas by active trials, top 10 of 45

Leukemia (21) · Multiple Myeloma (17) · Crohn's Disease (16) · Lung Cancer (15) · Ulcerative Colitis (15) · Migraine (14) · Non-Small Cell Lung Cancer (NSCLC) (13) · Ovarian Cancer (13) · Acute Myeloid Leukemia (AML) (12) · Atopic Dermatitis (10)

Get alerts when AbbVie's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free